Original InvestigationsOne-year Outcomes of Prasugrel Versus Ticagrelor In Acute Myocardial Infarction Treated With Primary Angioplasty: The PRAGUE-18 Study

2017

Background Early outcomes of patients in the PRAGUE-18 study did not find any significant differences between two potent P2Y12 inhibitors.

Keywords:

Correction
Cite
Save
Machine Reading By IdeaReader

0

References

0

Citations